CINECA IRIS Institutional Research Information System

BRIA, EMILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 604
EU - Europa 482
AS - Asia 224
SA - Sud America 11
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 1.327
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 595
IT - Italia 171
CN - Cina 107
IE - Irlanda 65
FR - Francia 55
SE - Svezia 50
SG - Singapore 32
GB - Regno Unito 27
JP - Giappone 27
IN - India 20
NL - Olanda 19
DE - Germania 16
VN - Vietnam 16
FI - Finlandia 10
BR - Brasile 8
GR - Grecia 8
AT - Austria 7
PL - Polonia 7
BA - Bosnia-Erzegovina 6
CA - Canada 6
ES - Italia 6
KR - Corea 6
BE - Belgio 5
TR - Turchia 5
TW - Taiwan 5
CH - Svizzera 4
HU - Ungheria 4
RS - Serbia 4
SI - Slovenia 4
UA - Ucraina 4
HR - Croazia 3
MX - Messico 3
AU - Australia 2
CO - Colombia 2
DK - Danimarca 2
EU - Europa 2
HK - Hong Kong 2
ME - Montenegro 2
NG - Nigeria 2
RO - Romania 2
SA - Arabia Saudita 2
AM - Armenia 1
AR - Argentina 1
IL - Israele 1
PT - Portogallo 1
Totale 1.327
Salva come PNG Salva come JPEG
Città #
Chandler 81
Dublin 65
Fairfield 38
Beijing 30
Torino 28
Houston 26
Nyköping 26
Redwood City 25
Chengdu 21
Medford 20
Milan 18
Ashburn 17
Princeton 16
Singapore 16
Woodbridge 15
Wilmington 14
Amsterdam 13
Rome 13
Hangzhou 11
Paris 11
Seattle 10
Turin 9
Cambridge 8
Dearborn 8
Dong Ket 8
Lexington 7
Ann Arbor 6
Banja Luka 6
Bari 6
London 6
Preveza 6
Seoul 6
Shanghai 6
Villeurbanne 6
Chaponost 5
Hebei 5
Mumbai 5
Belgrade 4
Bologna 4
Boston 4
Brookline 4
Hiroshima 4
Newcastle upon Tyne 4
Norwalk 4
Padova 4
Pisa 4
San Francisco 4
Vienna 4
Budapest 3
Chennai 3
Chicago 3
Coyoacán 3
Duncan 3
Genay 3
Guangzhou 3
Helsinki 3
Higashinakano 3
Jacksonville 3
Madrid 3
New Delhi 3
New York 3
Philadelphia 3
Piemonte 3
Pune 3
San Diego 3
Shenyang 3
Tokyo 3
Toulouse 3
Vancouver 3
Warsaw 3
Zagreb 3
Abuja 2
Adana 2
Andover 2
Atlanta 2
Authie 2
Bengaluru 2
Birmingham 2
Brooklyn 2
Casalbordino 2
Celje 2
Champaign 2
Dossobuono 2
Flanders 2
Florence 2
Fuzhou 2
Genoa 2
Hyderabad 2
Jinan 2
Kunming 2
Lake Villa 2
Lappeenranta 2
Lenart v Slov. Goricah 2
Liverpool 2
Los Angeles 2
Marietta 2
Messina 2
Motomachi 2
Mutterstadt 2
Nanjing 2
Totale 788
Salva come PNG Salva come JPEG
Nome #
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 318
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50% 257
Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study 80
Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation 78
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial 72
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 71
Chemotherapy-induced nausea and vomiting (CINV) in patients with advanced lung cancer during the first-line treatment: assessment by physicians, nurses, and patients from an Italian multicenter survey. 69
First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status 55
Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. 54
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes 47
External Validation of a Prognostic Model for Squamous-Cell Lung Cancer and Impact of Adjuvant Treatment in >1,300 Patients: Topic: Neoadjuvant and Adjuvant Chemotherapy 45
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features 44
Prognostic Model for Resected Squamous-Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment. 41
Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis 36
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status 35
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 26
Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences 24
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed 11
RET-MAP: An international multi-center study on clinicobiologic features and treatment response in patients with lung cancer harboring a RET fusion 7
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program 7
Totale 1.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.405
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.405
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 9 9 8 18 14 17 30 27 13 16 19 3
2020/2021191 19 5 7 9 20 8 13 15 25 18 10 42
2021/2022222 8 12 13 12 16 8 16 15 8 20 62 32
2022/2023404 34 25 9 17 31 85 32 31 69 23 25 23
2023/2024269 29 52 20 15 19 20 11 16 5 31 26 25
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 1.377